Zloipelmen1 - FACEIT level 10, 2,501 ELO

Russia
On FACEIT since 2025 133 matches tracked 119 matches in 30 days
ELO ▲ 147
2,501
30-day peak: 2,501
Rank EU
#56,801
Russia #16,131 in Russia
Last updated:

Zloipelmen1 at a glance

Level 10 2,501 ELO best map Mirage (65%)
2,500-2,749 ELO

Last 20 matches compared with 2,995 players in this group: K/R, ADR and win rate above average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 95%
1.28
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.32 ConsistencyShare of matches with a rating of 0.90 or higher. 85%
K/R
0.95
better than 97% of players
2,500-2,749 ELO avg: 0.74
Last 12 months
ADR
103.2
better than 98% of players
2,500-2,749 ELO avg: 81.1
Last 12 months
Win rate
55%
better than 60% of players
2,500-2,749 ELO avg: 51%
Last 12 months

Facts

99 ELO Next goal ELO to 2,600
12 Comebacks last 90 days
12 W · 8 L Overtime in overtime
Mirage Favorite map 52 of 133 matches
Mirage 65% Map pool tip weakest: Anubis 44%
4 knife kills Rare kills last 90 days
18:00-24:00 Best time 64% win rate vs. 58%
FormMapsTiming

99 ELO away from 2,600 ELO. 12 wins after trailing at halftime (last 90 days). 20 matches in overtime, 12 of them won (last 90 days). Most played: Mirage (52 of 133 matches). Strongest map: Mirage (65% win rate, 52 matches). Weakest: Anubis (44%, 16 matches). 4 knife kills (last 90 days). Best results between 18:00 and 24:00: 64% win rate vs. 58% overall (59 matches).

About Zloipelmen1

Zloipelmen1 plays CS2 on FACEIT level 10 with 2,501 ELO. The stats cover 133 matches. Zloipelmen1 plays Mirage the most and wins it the most: 65% win rate in 52 matches. Biggest strength: Damage per round (ADR) at 104.0, better than 99% of level 10 · 2,500-2,749 ELO players. Zloipelmen1 won 12 matches after trailing at halftime (last 90 days). Last 20 matches: 11 wins, 9 losses, +26 ELO. Zloipelmen1 does best between 18:00 and 24:00: 64% win rate in 59 matches.